These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 23695834

  • 1. Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii.
    Napier BA, Burd EM, Satola SW, Cagle SM, Ray SM, McGann P, Pohl J, Lesho EP, Weiss DS.
    mBio; 2013 May 21; 4(3):e00021-13. PubMed ID: 23695834
    [Abstract] [Full Text] [Related]

  • 2. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V, Gartenmann S, Tötzl M, Lucchini V, Schellhorn B, Pieren M, Lociuro S, Gitzinger M, Tigges M, Bumann D, Kemmer C.
    mBio; 2019 Jul 16; 10(4):. PubMed ID: 31311879
    [Abstract] [Full Text] [Related]

  • 3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar 16; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 4. Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in Acinetobacter baumannii.
    Lee JY, Hong YK, Ko KS.
    Diagn Microbiol Infect Dis; 2020 Apr 16; 96(4):114965. PubMed ID: 32019695
    [Abstract] [Full Text] [Related]

  • 5. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
    Kamoshida G, Yamada N, Nakamura T, Yamaguchi D, Kai D, Yamashita M, Hayashi C, Kanda N, Sakaguchi M, Morimoto H, Sawada T, Okada T, Kaya Y, Takemoto N, Yahiro K.
    Microbiol Spectr; 2022 Oct 26; 10(5):e0192822. PubMed ID: 36173297
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X, Garcia de la Maria C, López-Rojas R, Pachón J, Giralt E, Vila J.
    Clin Microbiol Infect; 2012 Apr 26; 18(4):383-7. PubMed ID: 21672084
    [Abstract] [Full Text] [Related]

  • 7. Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.
    García-Quintanilla M, Pulido MR, Moreno-Martínez P, Martín-Peña R, López-Rojas R, Pachón J, McConnell MJ.
    Antimicrob Agents Chemother; 2014 May 26; 58(5):2972-5. PubMed ID: 24566189
    [Abstract] [Full Text] [Related]

  • 8. Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii.
    Sakoulas G, Rose W, Berti A, Olson J, Munguia J, Nonejuie P, Sakoulas E, Rybak MJ, Pogliano J, Nizet V.
    Antimicrob Agents Chemother; 2017 Feb 26; 61(2):. PubMed ID: 27872080
    [Abstract] [Full Text] [Related]

  • 9. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M, Carretero-Ledesma M, Moreno-Martínez P, Martín-Peña R, Pachón J, McConnell MJ.
    Int J Antimicrob Agents; 2015 Dec 26; 46(6):696-702. PubMed ID: 26391380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D, Dan M, Maciuca IE, Ciucu L, Dabija ER, Guguianu E, Panzaru CV.
    Eur J Clin Microbiol Infect Dis; 2015 Oct 26; 34(10):2069-74. PubMed ID: 26239064
    [Abstract] [Full Text] [Related]

  • 12. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E, Yoon EJ, McGann P, Snesrud E, Kwak Y, Milillo M, Onmus-Leone F, Preston L, St Clair K, Nikolich M, Viscount H, Wortmann G, Zapor M, Grillot-Courvalin C, Courvalin P, Clifford R, Waterman PE.
    J Infect Dis; 2013 Oct 01; 208(7):1142-51. PubMed ID: 23812239
    [Abstract] [Full Text] [Related]

  • 13. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M, Rolain JM.
    Int J Antimicrob Agents; 2012 Feb 01; 39(2):105-14. PubMed ID: 22113193
    [Abstract] [Full Text] [Related]

  • 14. Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture.
    Wang X, Loh B, Gordillo Altamirano F, Yu Y, Hua X, Leptihn S.
    Emerg Microbes Infect; 2021 Dec 01; 10(1):2205-2219. PubMed ID: 34736365
    [Abstract] [Full Text] [Related]

  • 15. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D, Elzayat MG, Diab AA, El-Shqanqery HE, Samir O, Bakry U, Hassan R, Elanany M, Shalaby L, Sayed AA.
    mSphere; 2021 Dec 22; 6(6):e0072521. PubMed ID: 34787450
    [Abstract] [Full Text] [Related]

  • 16. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.
    Lin L, Nonejuie P, Munguia J, Hollands A, Olson J, Dam Q, Kumaraswamy M, Rivera H, Corriden R, Rohde M, Hensler ME, Burkart MD, Pogliano J, Sakoulas G, Nizet V.
    EBioMedicine; 2015 Jul 22; 2(7):690-8. PubMed ID: 26288841
    [Abstract] [Full Text] [Related]

  • 17. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E, Gómez-Gil R, Sanz S, González-Zorn B, Daoud Z, Mingorance J, Suárez M.
    Int J Antimicrob Agents; 2017 Jun 22; 49(6):727-733. PubMed ID: 28438568
    [Abstract] [Full Text] [Related]

  • 18. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC, Choi JA, Jang SJ, Jeong SH, Kim CM, Choi IS, Kang SH, Park G, Moon DS.
    Ann Lab Med; 2016 Mar 22; 36(2):124-30. PubMed ID: 26709259
    [Abstract] [Full Text] [Related]

  • 19. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S, Douraghi M, Adibhesami H, Zeraati H, Rahbar M, Boroumand MA, Aliramezani A, Ghourchian S, Mohammadzadeh M.
    Lett Appl Microbiol; 2016 Dec 22; 63(6):466-472. PubMed ID: 27626896
    [Abstract] [Full Text] [Related]

  • 20. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
    Cai Y, Chai D, Wang R, Liang B, Bai N.
    J Antimicrob Chemother; 2012 Jul 22; 67(7):1607-15. PubMed ID: 22441575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.